Overall Conference Chair and co-Chair of TOHS Sub-Committee
Dr. Peter Liu is the Chief Scientific Officer and Vice President of Research at the University of Ottawa Heart Institute. Dr. Liu has designed the Ottawa region cardiovascular research strategy (ORACLE) and is implementing it in stages. Dr. Liu also directs several large-scale national and international research programs. Dr. Liu has been recognized with numerous awards, including both the Research Achievement Award and the Life Time Achievement Award of the Canadian Cardiovascular Society, the Rick Gallop Award of the Heart & Stroke Foundation, and the Institute of Circulatory & Respiratory Health Distinguished Lecture Award of CIHR, and the Margolese Award from UBC, amongst others.
Ottawa Heart Research Conference subcommittee Chair
David Birnie, MD, is staff cardiac electrophysiologist and Director of the Arrhythmia Service at the University of Ottawa Heart Institute. He is also Director, Clinical Research, Division of Cardiology at the University of Ottawa Heart Institute and Associate Professor in the Division of Cardiology, Department of Medicine, at the University of Ottawa. Dr. Birnie leads the Ottawa region strategic research Innovation Cluster on Atrial Fibrillation.
Toronto Ottawa Heart Summit subcommittee co-Chair
Michael Farkouh, MD
Dr. Farkouh is Director of the Heart and Stroke Richard Lewar Centre of Excellence, and Associate Professor, University of Toronto. He has designed and conducted numerous pivotal clinical trials including: CHEER (Chest Pain Evaluation in the Emergency Room), TARGET, STATUS and FREEDOM (enrolling). His areas of research include: evaluation of chest pain syndromes, diabetes and heart diseases and the relationship of anti-inflammatory agents and heart disease.
Eastern Ontario Cardiovascular Summit partnered event Chair
Dr. Michael Froeschl is an Interventional Cardiologist at the University of Ottawa Heart Institute and an Assistant Professor in the Department of Medicine at the University of Ottawa. Dr. Froeschl is the organizer for the Eastern Ontario Cardiovascular Summit. Dr. Froeschl’s clinical interests include interventional cardiology, cardiac critical care, and general cardiology. His chief academic interest is medical education. In 2007, Dr. Froeschl won the Royal College of Physicians and Surgeons of Canada Fellowship for Studies in Medical Education. In 2011, he completed a master’s degree in health professions education in the Faculty of Medicine at Maastricht University in the Netherlands.
Peter Backx, PhD, DVM (OHRC)
Dr. Backx is a Senior Scientist at the Toronto General Research Institute. He is also a Professor at the Departments of Physiology and Medicine at University of Toronto. His research interests focus in two main areas: the molecular structure of cardiac ion channels and the physiological role of cardiac ion channels in normal and diseased myocardium.
Mark Fraser, MD, CCFP, FCFP (OHRC, TOHS)
Dr. Fraser is a Fellow of the College of Family Physicians, is on active Staff at the Queensway Carleton Hospital, and is Co-Lead Physician of the West Carleton Family Health Team, which was awarded Family Practice of the Year by the Ontario College of Family Physicians for 2010. In 2013, Dr. Fraser received an Award of Excellence from the College of Family Physicians of Canada for innovation in chronic disease management and health promotion. He was honoured by Canada Health Infoway in 2013 as co-developer of West Carleton FHT’s national award- winning Patient Health Portal. His special interest lies in medical informatics and the application of EMR data analytics to optimize population-based management of cardiovascular and other chronic diseases in Primary Care.
Anthony Tang, MD FRCPC (OHRC)
Dr. Anthony Tang is Professor of Medicine at Western University and Adjunct Professor of Medicine in the Faculty of Medicine at the University of Ottawa. Dr. Tang is presently Staff Electrophysiologist, Division of Cardiology, London Health Science Centre and Chair of Cardiovascular Population Health. He obtained his MD from the University of Toronto and his clinical training in Internal Medicine and Cardiology at the University of Ottawa. Dr. Tang obtained a Heart and Stroke Research Fellowship to receive electrophysiology research training at Duke University Medical Centre. He is member of the Ontario Medical Association, American College of Cardiology (Fellow), Canadian Cardiovascular Society, Heart Rhythm Society (Fellow), and American Heart Association. Currently, he is the Scientific Director for the Canadian Arrhythmia Network (CANet), which is funded by the Network of Excellence (NCE) from 2015-20.
Atul Verma, MD, FRCPC (OHRC, TOHS)
Dr. Verma specializes in cardiac electrophysiology, with practice in ablation techniques, percutaneous biventricular and basic device implantation, and in the diagnosis and management of cardiac arrhythmia and device problems. In particular, Dr. Verma trained at the Cleveland Clinic in the ablation of complex rhythm disorders such as atrial fibrillation and ventricular tachycardia. His research interests and activities include the evaluation of novel catheter-based technologies and cardiac imaging techniques, and in clinical database research and clinical trial design, with a current focus on comparing different catheter-based ablation techniques for arrhythmia control.
He has authored or co-authored over 70 articles and abstracts on electrophysiology issues, ablation, and arrhythmia. Dr. Verma has received many honours and awards during his career including being a Heart and Stroke Foundation of Canada Research Fellowship awardee (2003-05), which is a peer-reviewed award for two years of funding for electrophysiology research. Dr. Verma serves on the executive of the Canadian Heart Rhythm Society and has helped draft several national and international guidelines including the CCS Atrial fibrillation guidelines.
Bradley Strauss, MD, PhD (TOHS)
Dr. Strauss is Senior Scientist at Sunnybrook Health Sciences Centre. His research interests focus on: restenosis after coronary interventions; evaluation of new coronary devices and imaging modalities; and pathophysiology and new therapies for treating chronic total occlusions.